UBS Group AG

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1610520 ZURICH, V8

Back to RARE Full portfolio

Position in RARE

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$17,445,902

+$2,063,249 QoQ

Shares Held

832,740

+24.5% QoQ

Ownership

0.846%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.4718639671446.ToString("F0")% Shared 0.ToString("F0")% None 0.528136032855393.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. RARE ranks #76 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

All Filings in RARE

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,445,902	832,740	+24.5%	Shares	Defined	2026-05-05
2025-12-31	$15,382,653	668,811	+22.3%	Shares	Defined	2026-01-29
2025-09-30	$16,454,511	547,025	+24.2%	Shares	Defined	2025-11-13
2025-06-30	$16,014,106	440,432	-6.2%	Shares	Defined	2025-08-14
2025-03-31	$16,999,942	469,482	+44.2%	Shares	Defined	2025-05-13
2024-12-31	$13,700,136	325,651	+249.9%	Shares	Defined	2025-02-14
2024-09-30	$5,169,981	93,069	-52.5%	Shares	Defined	2024-11-14
2024-06-30	$8,051,118	195,891	+15.8%	Shares	Defined	2024-08-14
2024-03-31	$7,898,219	169,163	+192.6%	Shares	Defined	2024-05-13
2023-12-31	$2,764,999	57,821	+24.6%	Shares	Defined	2024-02-09
2023-09-30	$1,653,873	46,392	-26.9%	Shares	Defined	2023-11-09
2023-06-30	$2,927,869	63,470	-15.4%	Shares	Defined	2023-08-11
2023-03-31	$3,006,697	74,980	-54.6%	Shares	Defined	2023-05-12
2022-12-31	$7,648,990	165,098	+457.0%	Shares	Defined	2023-02-08
2022-09-30	$1,227,515	29,643	-37.1%	Shares	Defined	2022-11-10
2022-06-30	$2,812,908	47,149	-48.9%	Shares	Defined	2022-08-10
2022-03-31	$6,705,512	92,337	+45.7%	Shares	Defined	2022-05-16
2021-12-31	$5,329,455	63,378	+12.8%	Shares	Defined	2022-02-14
2021-09-30	$5,067,324	56,185	+119.2%	Shares	Defined	2021-11-15
2021-06-30	$2,443,439	25,626	-48.4%	Shares	Defined	2021-08-13
2021-03-31	$5,650,757	49,629	+79.6%	Shares	Defined	2021-05-12
2020-12-31	$3,824,405	27,627	+5.6%	Shares	Defined	2021-02-11
2020-09-30	$2,149,843	26,157	-17.5%	Shares	Defined	2020-11-12
2020-06-30	$2,481,059	31,719	-75.8%	Shares	Defined	2020-07-31
2020-03-31	$5,812,776	130,830	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.